Robin Marchant has acted for private and public corporations, private equity funds and investment banks based in the U.K., the U.S., Europe and Russia on a broad range of corporate and commercial work.

Bio

Mr. Marchant’s work has included private and public M&A, private equity transactions, equity and debt security issues, share capital restructurings and buybacks, project finance, and general corporate matters. He is recognized in the Russia Corporate/M&A section of Chambers Global and the Russia Corporate/M&A: High-End Capability section of Chambers Europe and also has been named in IFLR1000.

Mr. Marchant’s experience has included advising:

  • Renault-Nissan Alliance in relation to its investments in AvtoVAZ, a leading Russian car manufacturer, including:
    • the acquisition by Renault of a 25 percent stake in AvtoVAZ, and the subsequent recapitalisation of AvtoVAZ by its shareholders via contribution of equipment, technology and cash with the total value of more than €950 million; and
    • the creation of a joint venture between Renault-Nissan Alliance and Rostec, giving Renault-Nissan Alliance control over AvtoVAZ and the multibillion-ruble recapitalization of AvtoVAZ;
  • Daimler AG in relation to its investment in Kamaz, Russia’s leading trucks manufacturer, and the creation of a joint venture with Rostec and Avtoinvest LLC;
  • Megapolis, a major FMCG logistics and distribution business in Russia, in the establishment of a joint venture with Philip Morris and Japan Tobacco;
  • Vardanyan, Broitman and Partners Ltd. in relation to the separation of the joint businesses of Ruben Vardanyan and Gagik Adibekyan;
  • Crispian Investments Limited in relation to its proposed sale of its investment in Norilsk Nickel;
  • Svoboda Corporation on various acquisitions, creations of joint ventures and corporate reorganisations in relation to various retail businesses, including Ulmart and Rive Gauche;
  • Fresenius Kabi AG on its proposed joint venture with Sistema PJSFC to combine their respective pharmaceutical businesses;
  • Revlon on its acquisition by way of auction of The Colomer Group from CVC Capital Partners’ funds for US$665 million;
  • Wm. Wrigley. Jr. Company on its acquisition of premium Russian chocolatier A. Korkunov, the establishment of a joint venture with Korkunov, and its later merger with Mars, Incorporated;
  • CME Group, the world’s leading derivatives marketplace, in relation to its acquisition of Elysian Systems Ltd., an independent provider of electronic trading and market technology;
  • Renaissance Partners in relation to the creation of a joint venture for the establishment of a soya protein processing plant in Finland;
  • Simon Glick Investments in relation to the restructuring and refinancing of Songbird Estates (a majority shareholder of Canary Wharf Group plc) and the creation of a warrant funding instrument;
  • TPG Capital in relation to Vita Group’s restructuring by means of a creditors’ and members’ scheme of arrangement;
  • the management of Vita Group in relation to the creation of its equity incentive scheme;
  • Berkeley Group Holdings on its return of £13 per share to shareholders and the creation of a long-term incentive plan for management;
  • Imerys SA in its US$652.8 million acquisition of S&B Industrial Minerals GmbH. Both companies are producers of industrial minerals and pigments;
  • Three Delta LLP in relation to:
    • its consideration of a possible offer for J Sainsbury plc, an owner and operator of supermarkets and convenience stores; and
    • The Delta Fund’s acquisition of the Senad Group, its acquisition of the Four Seasons Health Care Group and its subsequent restructuring involving a proposed cross-border (German/English) merger under the European Directive on Cross-Border Mergers;
  • London Clubs International plc on a Class 1 disposal of a casino and on its later takeover by Harrah’s Entertainment, Inc.;
  • Gazprombank in relation to the auction sale of a material trading interest;
  • Gazprom Neft in relation to a proposed auction sale of an oil field;
  • TMK Group, a listed Russian pipe producer, in relation to a proposed joint venture;
  • Itera Group, a private Russian gas producer, in relation to the sale of certain assets and on a proposed joint venture; and
  • funds advised by Castle Harlan, Inc., a U.S. private equity house, on its acquisition of the Polypipe Group and its subsequent restructurings and refinancings.

Credentials

Education

  • Postgraduate Diploma in Legal Practice, University of Law Guildford, 1995
  • LL.B., University of Southampton, 1992

Admissions

  • England & Wales

Robin F. Marchant

European Counsel, Mergers and Acquisitions; Private Equity
robin.marchant@skadden.com